Sporotrichosis in a horse.

This case report describes a horse with skin nodules caused by the fungus Sporothrix (S. schenckii complex), diagnosed by tissue stains and culture, and treated with antifungals that halted further spread. It emphasizes that although sporotrichosis is rare in Europe, it should be considered when nodules track along lymph vessels.

What the paper is about and why it matters

• Reports a confirmed case of equine sporotrichosis presenting as nodular lesions along lymphatics (a “sporotrichoid” or cutaneolymphatic pattern).
• Underscores the need to include fungal causes in the differential diagnosis of nodular lymphangitis in horses, even in regions where the disease is uncommon.

Case presentation

• Patient: 9-year-old male Arabian horse.
• Main complaint: Multiple nodules on the inner aspect of the right hind limb.
• Distribution: Lesions aligned along lymphatic vessels, consistent with ascending lymphangitic spread.
• Clinical implication: Pattern strongly suggests diseases that travel via lymphatics, classically sporotrichosis.

Diagnostic workup and key findings

• Histopathology: Granulomatous inflammation with multinucleated giant cells, a typical host response to chronic fungal infection.
• Special stains:
  • PAS (Periodic acid–Schiff) and Grocott’s methenamine silver (GMS) highlighted spheroid yeast-like organisms with occasional budding throughout the tissue.
  • These stains are standard for demonstrating fungal cell walls and increase sensitivity when organisms are sparse.
• Microbiology:
  • Culture from a fresh nodule grew Sporothrix cf. schenckii, confirming the etiologic agent.
  • “cf.” indicates identity consistent with S. schenckii (sensu lato), acknowledging limitations of morphology-based speciation without molecular typing.
• Interpretation: Concordant pathology plus culture is the diagnostic gold standard for sporotrichosis.

About Sporothrix and pathogenesis

• Etiology: Thermally dimorphic fungi in the Sporothrix schenckii species complex (yeast in tissues; filamentous mold in the environment and at lower culture temperatures).
• Source and transmission: Traumatic inoculation from contaminated plant material, soil, or animal scratches/bites; organisms then spread along lymphatics.
• Typical clinical form in animals and humans: Lymphocutaneous (nodules or ulcers ascending along lymphatic channels), matching this case.

Treatment and outcome in the case

• Intervention: Antifungal therapy was initiated after culture confirmation.
• Outcome reported: Treatment halted further extension of the granulomatous lesions (disease progression stopped).
• Context from veterinary practice:
  • Common equine therapies include oral iodides (sodium or potassium iodide) and azoles (e.g., itraconazole), often for weeks to months.
  • Monitoring is needed for adverse effects (e.g., iodism with iodides; hepatic effects with azoles) and for clinical resolution.

Differential diagnoses for nodular lymphangitis in horses

• Bacterial: Corynebacterium pseudotuberculosis (ulcerative lymphangitis), Nocardia spp., Staphylococcus spp., atypical mycobacteria.
• Fungal/oomycete: Pythium insidiosum (pythiosis), zygomycetes (mucormycosis), Histoplasma capsulatum var. farciminosum (epizootic lymphangitis; regionally restricted).
• Parasitic/granulomatous: Habronemiasis (“summer sores”).
• Neoplastic or sterile granulomatous conditions, though the lymphangitic pattern favors infectious causes like Sporothrix.

Epidemiology and public health relevance

• Geography: Sporotrichosis is uncommon in Europe but more frequently encountered in parts of the Americas, including the southern United States.
• Reservoirs: Environmental saprophyte associated with soil and decaying vegetation; animal-associated transmission is also recognized in some regions.
• Zoonotic considerations: Sporothrix spp. are zoonotic; exudates from lesions can pose a risk to handlers. Use of gloves and hygiene during specimen handling and wound care is recommended.

Significance and takeaways for clinicians

• Consider sporotrichosis when nodules track along lymphatics, even in low-prevalence regions.
• Obtain biopsies for histopathology with fungal stains and perform culture to confirm diagnosis, as organisms may be few in tissue sections.
• Initiate targeted antifungal therapy promptly to prevent progression and further lymphatic dissemination.
• Implement biosecurity and personal protective measures during sampling and treatment.

Limitations and unanswered questions

• Single-case nature limits generalizability and does not quantify treatment efficacy or optimal duration.
• Lack of species-level molecular identification within the S. schenckii complex and absence of antifungal susceptibility data leave therapeutic nuances unspecified.
• Long-term outcome beyond halting lesion extension was not detailed.